Need for awareness about interaction between nonprescription intranasal corticosteroids and pharmacokinetic enhancers
| Autor: | Roxanne F. Underwood, Brooklyn Nelson, L. Brian Cross, Katelyn M. Alexander, David Cluck |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Pharmacology
medicine.medical_specialty Protease Adrenal cortex hormones business.industry Health Policy medicine.medical_treatment Nonprescription Drugs Pharmacy Surgery Pharmacokinetics Adrenal Cortex Hormones Antiretroviral Therapy Highly Active medicine Humans Drug Interactions Protease Inhibitors Nasal administration business Administration Intranasal |
| Zdroj: | American Journal of Health-System Pharmacy. 72:1086-1088 |
| ISSN: | 1535-2900 1079-2082 |
| DOI: | 10.2146/ajhp150179 |
| Popis: | The recent availability of nonprescription intranasal corticosteroids presents a risk to patients receiving protease inhibitors and other regimens containing pharmacokinetic enhancers.[1][1] However, the significance of this risk may not be fully appreciated by the medical and pharmacy communities |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|